Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAST Trial: Multi-modal Analgesic Strategies in Trauma
NCT03472469Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Apr 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetaminophen, ketorolac, naproxen, gabapentin, lidocaine 10% oropharyngeal spray in acute pain, sponsored by UTHealth Houston. Started Apr 2018; status: completed.
02
Drugs
acetaminophenketorolacnaproxengabapentinlidocaine 10% oropharyngeal spray
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03472469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03472469.